Literature DB >> 21182930

Cancer induces inflammation and depressive-like behavior in the mouse: modulation by social housing.

Donald M Lamkin1, Susan K Lutgendorf, David Lubaroff, Anil K Sood, Terry G Beltz, Alan Kim Johnson.   

Abstract

Considerable data demonstrate a high prevalence of depressive symptoms in cancer patients. This study introduces an experimental model to examine the effect of tumor on depressive-like behavior. Female C57BL/6 mice were injected i.p. with syngeneic ID8 ovarian carcinoma. Experiment 1 measured sucrose intake before and after tumor incubation to assess the effect of tumor on anhedonic depressive-like behavior. Experiment 2 examined effects of tumor and social housing on anhedonia and a second depressive-like behavior, tail suspension test (TST) immobility. Systemic proinflammatory and antiinflammatory cytokines were measured following each experiment. Additional behaviors assessed the specificity of tumor's effect on depressive-like behavior. Tumor caused a reduction in sucrose intake relative to baseline and control levels (P<.05). Moreover, individually-housed tumor-bearing mice exhibited a lower sucrose preference than group-housed tumor-bearing or control mice in either housing condition (P<.05). Although tumor-bearing mice exhibited less locomotion than controls (P<.001), there was no significant effect of tumor on TST immobility. Tumor caused higher levels of systemic proinflammatory and antiinflammatory cytokines and smaller body weight (P<.05), but appetite and motor capacity were not significantly affected. Statistical mediation analysis showed that circulating interleukin-6 partially mediated the effect between tumor and home cage locomotion (P<.01) but not between tumor and sucrose intake. It is concluded that tumor elicits anhedonic depressive-like behavior in a murine model of ovarian cancer. This may have important implications for etiology of depression in the clinical cancer setting.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182930      PMCID: PMC3039064          DOI: 10.1016/j.bbi.2010.12.010

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  44 in total

1.  Paroxetine for the prevention of depression induced by high-dose interferon alfa.

Authors:  D L Musselman; D H Lawson; J F Gumnick; A K Manatunga; S Penna; R S Goodkin; K Greiner; C B Nemeroff; A H Miller
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

2.  Limitations on the use of the C57BL/6 mouse in the tail suspension test.

Authors:  A J Mayorga; I Lucki
Journal:  Psychopharmacology (Berl)       Date:  2001-04       Impact factor: 4.530

3.  The role of tumor necrosis factor (TNF) in the febrile and metabolic responses of rats to intraperitoneal injection of a high dose of lipopolysaccharide.

Authors:  B Töllner; J Roth; B Störr; D Martin; K Voigt; E Zeisberger
Journal:  Pflugers Arch       Date:  2000-10       Impact factor: 3.657

4.  Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.

Authors:  A D Santin; S Bellone; A Ravaggi; J Roman; C V Smith; S Pecorelli; M J Cannon; G P Parham
Journal:  BJOG       Date:  2001-08       Impact factor: 6.531

5.  Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

Authors:  Lucile Capuron; Jane F Gumnick; Dominique L Musselman; David H Lawson; Andrea Reemsnyder; Charles B Nemeroff; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2002-05       Impact factor: 7.853

Review 6.  Depression in advanced disease: a systematic review Part 1. Prevalence and case finding.

Authors:  M Hotopf; J Chidgey; J Addington-Hall; K Lan Ly
Journal:  Palliat Med       Date:  2002-03       Impact factor: 4.762

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Distinct roles for cyclooxygenases 1 and 2 in interleukin-1-induced behavioral changes.

Authors:  Artur H Swiergiel; Adrian J Dunn
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

9.  Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients.

Authors:  Susan K Lutgendorf; Aliza Z Weinrib; Frank Penedo; Daniel Russell; Koen DeGeest; Erin S Costanzo; Patrick J Henderson; Sandra E Sephton; Nicolas Rohleder; Joseph A Lucci; Steven Cole; Anil K Sood; David M Lubaroff
Journal:  J Clin Oncol       Date:  2008-09-08       Impact factor: 44.544

10.  Determination of the estrous cycle phases of rats: some helpful considerations.

Authors:  F K Marcondes; F J Bianchi; A P Tanno
Journal:  Braz J Biol       Date:  2003-02-11       Impact factor: 1.651

View more
  37 in total

Review 1.  Biobehavioral factors and cancer progression: physiological pathways and mechanisms.

Authors:  Susan K Lutgendorf; Anil K Sood
Journal:  Psychosom Med       Date:  2011-10-21       Impact factor: 4.312

Review 2.  Translational approaches to treatment-induced symptoms in cancer patients.

Authors:  Robert Dantzer; Mary W Meagher; Charles S Cleeland
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

Review 3.  Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors:  Julienne E Bower; Donald M Lamkin
Journal:  Brain Behav Immun       Date:  2012-07-06       Impact factor: 7.217

4.  Peripheral tumors alter neuroinflammatory responses to lipopolysaccharide in female rats.

Authors:  Leah M Pyter; Sarah El Mouatassim Bih; Husain Sattar; Brian J Prendergast
Journal:  Brain Res       Date:  2014-01-20       Impact factor: 3.252

5.  Assessment of depression in a rodent model of spinal cord injury.

Authors:  Kelsey Luedtke; Sioui Maldonado Bouchard; Sarah A Woller; Mary Katherine Funk; Miriam Aceves; Michelle A Hook
Journal:  J Neurotrauma       Date:  2014-05-08       Impact factor: 5.269

Review 6.  Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.

Authors:  Andrew Schrepf; Susan K Lutgendorf; Leah M Pyter
Journal:  Brain Behav Immun       Date:  2015-05-06       Impact factor: 7.217

Review 7.  Psychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovations.

Authors:  Paige Green McDonald; Mary O'Connell; Susan K Lutgendorf
Journal:  Brain Behav Immun       Date:  2013-01-16       Impact factor: 7.217

Review 8.  When is it socially acceptable to feel sick?

Authors:  Patricia C Lopes
Journal:  Proc Biol Sci       Date:  2014-08-07       Impact factor: 5.349

9.  Novel rodent model of breast cancer survival with persistent anxiety-like behavior and inflammation.

Authors:  Leah M Pyter; Lorena P Suarez-Kelly; William E Carson; Jasskiran Kaur; Joshua Bellisario; Savannah R Bever
Journal:  Behav Brain Res       Date:  2017-05-04       Impact factor: 3.332

10.  Tumor-Associated Fatigue in Cancer Patients Develops Independently of IL1 Signaling.

Authors:  Aaron J Grossberg; Elisabeth G Vichaya; Diana L Christian; Jessica M Molkentine; Daniel W Vermeer; Phillip S Gross; Paola D Vermeer; John H Lee; Robert Dantzer
Journal:  Cancer Res       Date:  2017-12-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.